Veterinary/Animal Vaccines Market (Live Attenuated, DNA, Recombinant) Worth $8.6 Billion by 2018 - New Report by MarketsandMarkets

Share Article

The factors responsible for the growth of the animal vaccine market include increasing incidences of zoonotic diseases in humans, growing prevalence of animal diseases, and increasing investments by government bodies, animal welfare associations, and leading players.



Pfizer (Zoetis) (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada Inc. (Canada), and Ceva (France)

The “"Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] – Global Forecast to 2018", analyzes and studies the major market drivers, restraints, and opportunities in Europe, North America, Asia, and the Rest of the World.

Browse 99 market data tables and 50 figures spread through 281 pages and in-depth TOC on “Veterinary Vaccines & Animal Vaccines Market"

Early buyers will receive 10% customization on this report.

The global animal vaccines market is in its growth phase and is estimated to be worth $5.8 billion in 2013. It is expected to grow at a healthy CAGR of 8.1% to reach $8.6 billion by 2018.

Inquiry Before Buying @

The global animal vaccines market, valued at $5.4 billion in 2012, is primarily driven by factors such as the growing prevalence of animal diseases, increasing incidences of zoonotic diseases in humans, increasing investments by government bodies and animal welfare associations,, and continuous innovations and introductions of new products. On the other hand, factors such as increasing maintenance costs for vaccines and consumers’ increasing preference for vegetarian food to avoid obesity will restrict the growth of the market.

The animal vaccines market studied is segmented by products, animal diseases, and technologies that are involved in developing vaccines for veterinary administration. The global animal vaccines market, by products, is further segmented into seven segments, such as companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. The livestock vaccines market is further sub-segmented into bovine vaccines and small ruminant vaccines, whereas the companion animal vaccines market is further classified into canine vaccines and feline vaccines. The livestock vaccines segment dominates the market with close to 37% share followed by porcine and poultry. The large share of these segments is attributed to their major use of animals related to the food industry (meat, chicken, eggs, and dairy products), which are considered as healthy sources of protein. However, the aquaculture and companion vaccine segments will witness a healthy growth rate in the near future.

On the basis of technology, the animal vaccines market has segments like live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines technology will be the fastest-growing technology due to its cost effectiveness and easy production, rapid development against emerging diseases, and added thermo-stability between 4°C to 20°C in comparison with traditional vaccines.

Ask for Free PDF Brochure @

Increasing investment opportunities in emerging and immature markets, growing prevalence of animal diseases, and increasing incidences of zoonotic diseases in humans are the key factors driving the growth of the animal vaccines market, globally. On the other hand, rising maintenance costs incurred for storage of vaccines and consumers’ preference for vegetarian diet will slow down the growth of the market.

Europe accounts for the largest share in the animal vaccines market, followed by North America. Europe and North America collectively hold around 70% share of the global animal vaccines market, and are fast reaching maturity. Asia, Africa, and LATAM are poised to grow at double-digit rates owing to increasing investments by companies in these markets and due to improving healthcare facilities for animals.

Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global animal vaccines market. Most of these companies have established their foothold in the market and new entrants will face challenges as far as making a mark in the industry is concerned. Additionally, stringent regulatory guidelines and the capital-intensive nature of the industry will make entry more difficult for new companies.

Browse Related Reports:

Small Animal Imaging (In Vivo) Market - By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017

Opportunity Analysis of H1N1 (swine flu) Vaccination Market

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets [email protected]
Connect with us on [email protected]

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
Follow us on
Visit website